TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35963206

Group type: EXPERIMENTAL
Intervention: Progressive functional exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (routine treatments)
Number of subjects: 60
Study: 32183453

Group type: EXPERIMENTAL
Intervention: 50% Human-animal Interaction (HAI) with Academic Stress Management (ASM) content
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: 100% Human-animal Interaction (HAI)
Number of subjects: 349

Group type: COMPARATOR
Intervention: 0% Human-animal Interaction (HAI) with Academic Stress Management (ASM) content
Number of subjects: 349
Study: 32013936

Group type: EXPERIMENTAL
Intervention: Silicone ureteral stents (Cook Medical)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Polyurethane ureteral stents (Rüsch, Teleflex)
Number of subjects: 50
Study: 36163982

Group type: EXPERIMENTAL
Intervention: Add-on parsaclisib 10 or 20 mg QD for 8 weeks then same dose QW
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Add-on parsaclisib 5 or 20 mg QD for 8 weeks then 5 mg QD
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (Ruxolitinib only)
Number of subjects: 67
Study: 34728684

Group type: COMPARATOR
Intervention: 2 mA multichannel anodal tDCS (atDCS) over the left dorsolateral prefrontal cortex (lDLPFC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 2 mA multichannel anodal tDCS (atDCS) combined with 2-back task
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (sham stimulation)
Number of subjects: 22
Study: 33586664

Group type: EXPERIMENTAL
Intervention: Deep Inspiration Breath-Hold (DIBH)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Free-Breathing (FB)
Number of subjects: 50
Study: 35512402

Group type: EXPERIMENTAL
Intervention: Pertuzumab added to adjuvant chemotherapy plus trastuzumab
Number of subjects: 4804

Group type: COMPARATOR
Intervention: Control group (adjuvant chemotherapy plus trastuzumab without pertuzumab)
Number of subjects: 4804
Study: 33340181

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Buprenorphine-naloxone (BUP-NX)
Number of subjects: 570
Study: 35837711

Group type: EXPERIMENTAL
Intervention: Evolocumab 140 mg every 2 weeks for 2 to 6 weeks before PCI
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no evolocumab)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Evolocumab group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 32000470

Group type: EXPERIMENTAL
Intervention: Presurgical cognitive impairment (PreCI)
Number of subjects: 934

Group type: EXPERIMENTAL
Intervention: Presurgical cognitive impairment (PreCI) and postoperative delirium (POD)
Number of subjects: 934

Group type: EXPERIMENTAL
Intervention: Amnestic presurgical cognitive impairment (PreCI)
Number of subjects: 934
Study: 35226723

Group type: EXPERIMENTAL
Intervention: Canakinumab (300 mg subcutaneous, 6 monthly treatments)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 33128206

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) plus TCM formula (TGYP and TGJPJD)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Entecavir (ETV) plus TCM placebo
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 596
Study: 34933219

Group type: EXPERIMENTAL
Intervention: Action-Based Cognitive Remediation (ABCR)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 34127008

Group type: EXPERIMENTAL
Intervention: Home-based enhanced knee flexion exercise program (KFEH)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard supervised physiotherapy (SPT)
Number of subjects: 119
Study: 33198514

Group type: EXPERIMENTAL
Intervention: Bodyweight-based strength training (BWST)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control session (CS)
Number of subjects: 11
Study: 32322048

Group type: EXPERIMENTAL
Intervention: Brown rice-based diet (BRD)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Wheat-based diet (WD)
Number of subjects: 39

Group type: COMPARATOR
Intervention: White rice-based diet (WRD)
Number of subjects: 39
Study: 35899310

Group type: EXPERIMENTAL
Intervention: HLX02
Number of subjects: 0

Group type: COMPARATOR
Intervention: trastuzumab
Number of subjects: 0
Study: 33792896

Group type: EXPERIMENTAL
Intervention: 1% glycopyrronium bromide cream applied for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.5%, 1%, and 2% glycopyrronium bromide cream applied topically for 2 weeks
Number of subjects: 0
Study: 32146225

Group type: EXPERIMENTAL
Intervention: Phrases with unpleasant connotation (n = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Objective phrases (n = 60)
Number of subjects: 120
Study: 36351733

Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 334

Group type: COMPARATOR
Intervention: Staples or sutures (Control)
Number of subjects: 334
Study: 34097448

Group type: EXPERIMENTAL
Intervention: HDL function markers (cholesterol efflux capacity)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel HDL markers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutics targeting HDL metabolism
Number of subjects: 0
Study: 32094219

Group type: EXPERIMENTAL
Intervention: Basic cost group (GP stated the weekly monetary cost)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cost comparison group (GP compared weekly cost to an everyday discretionary item)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NHS-funded programme (previous study for comparison)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intervention helpfulness
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intervention appropriateness
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Attendance at weight loss programme
Number of subjects: 60
Study: 34495439

Group type: EXPERIMENTAL
Intervention: Resin composite (2)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Bundled fiber post and resin composite (3)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Vertical fiber post and resin composite (4)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Horizontal fiber post and resin composite (5)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Woven fiber post and resin composite (6)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Composite endocrown (7)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (1)
Number of subjects: 76
Study: 32068354

Group type: EXPERIMENTAL
Intervention: BMS-986184 (150 mg subcutaneously every other week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model predictions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stochastic simulations
Number of subjects: 0
Study: 37661535

Group type: EXPERIMENTAL
Intervention: Havisure™ vaccine
Number of subjects: 528

Group type: COMPARATOR
Intervention: Havrix® vaccine
Number of subjects: 528
Study: 34187856

Group type: EXPERIMENTAL
Intervention: Dietary intervention designed to reduce total fat intake to 20% of energy and to increase vegetable, fruit, and grain consumption (n = 19,541)
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Comparison group (n = 29,294)
Number of subjects: 48835
Study: 32639235

Group type: EXPERIMENTAL
Intervention: RHB-102 (12 mg daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35983579

Group type: COMPARATOR
Intervention: Control
Number of subjects: 22616

Group type: EXPERIMENTAL
Intervention: Opioid justification
Number of subjects: 22616

Group type: EXPERIMENTAL
Intervention: Clinician comparison
Number of subjects: 22616

Group type: EXPERIMENTAL
Intervention: Opioid justification and clinician comparison
Number of subjects: 22616
Study: 34482041

Group type: EXPERIMENTAL
Intervention: Warm handoff intervention (female twelve-step volunteer met with each woman individually in jail and attended the first twelve-step meeting with her after release)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Enhanced standard care (a list of meetings and community resources)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Warm handoff intervention
Number of subjects: 189
Study: 35081599

Group type: EXPERIMENTAL
Intervention: Operative management (rib fixation)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Nonoperative management
Number of subjects: 124
Study: 34166447

Group type: EXPERIMENTAL
Intervention: MOGBA intervention (14 games-based activities delivered over 9 weeks)
Number of subjects: 904

Group type: EXPERIMENTAL
Intervention: MOGBA intervention
Number of subjects: 904
Study: 33371160

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 0
Study: 35590399

Group type: EXPERIMENTAL
Intervention: Bilateral high-definition transcranial random noise stimulation (HD-tRNS) combined with acoustic stimulation (AS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active HD-tRNS
Number of subjects: 0

Group type: COMPARATOR
Intervention: HD-tRNS alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electroencephalography (EEG) measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized questionnaires
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimum masking level (MML) audiological measurement
Number of subjects: 0
Study: 33438255

Group type: EXPERIMENTAL
Intervention: Individual education intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 35442180

Group type: EXPERIMENTAL
Intervention: Good CPAP adherence (≥4 hours/night)
Number of subjects: 1803

Group type: EXPERIMENTAL
Intervention: Severe OSA (AHI >40 events/h)
Number of subjects: 1803

Group type: COMPARATOR
Intervention: Usual care/poor CPAP adherence
Number of subjects: 1803

Group type: COMPARATOR
Intervention: Non-OSA group
Number of subjects: 1803
Study: 34625591

Group type: EXPERIMENTAL
Intervention: Experimental implant design
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control implant design
Number of subjects: 20
Study: 32469920

Group type: EXPERIMENTAL
Intervention: Timely, formative feedback and group feedback sessions
Number of subjects: 3
Study: 35641443

Group type: EXPERIMENTAL
Intervention: guided eCBT‐I
Number of subjects: 52

Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 52
Study: 33486637

Group type: EXPERIMENTAL
Intervention: Patients' prognostic awareness (PA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Caregivers' prognostic awareness (PA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Clinicians' prognostic awareness (PA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) correlation
Number of subjects: 16
Study: 34843069

Group type: EXPERIMENTAL
Intervention: Umbilical cord-derived mesenchymal stem cell (UC-MSC) treatment, administered as three infusions at 4-week intervals plus conventional treatment.
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group receiving conventional treatment only.
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: UC-MSC treatment.
Number of subjects: 219
Study: 36522208

Group type: EXPERIMENTAL
Intervention: Delamanid, linezolid, levofloxacin, and pyrazinamide for 9 months
Number of subjects: 214

Group type: COMPARATOR
Intervention: Conventional 20–24 month regimen
Number of subjects: 214
Study: 33595717

Group type: EXPERIMENTAL
Intervention: Consultation recording
Number of subjects: 133

Group type: COMPARATOR
Intervention: No consultation recording (Control)
Number of subjects: 133
Study: 33744350

Group type: EXPERIMENTAL
Intervention: BF-200 ALA
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 50
Study: 32618578

Group type: EXPERIMENTAL
Intervention: Immediate group (IG) received group education, a Fitbit, access to FitViz, and 4 biweekly phone calls from a PT over 8 weeks.
Number of subjects: 51

Group type: COMPARATOR
Intervention: Delay group (DG) received a monthly electronic newsletter in weeks 1 to 12 and started the same intervention in week 14.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Immediate group (IG)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Delay group (DG)
Number of subjects: 51
Study: 35811347

Group type: EXPERIMENTAL
Intervention: Atomoxetine plus fesoterodine (80-4 mg)
Number of subjects: 12
Study: 33713484

Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection
Number of subjects: 17

Group type: COMPARATOR
Intervention: Isotonic saline injection
Number of subjects: 17
Study: 35215544

Group type: EXPERIMENTAL
Intervention: Vegan diet (VegD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional mixed diet (MixD)
Number of subjects: 20
Study: 34127041

Group type: EXPERIMENTAL
Intervention: Educational pre-visit preparation (PVP) + usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exome sequencing (ES) + usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PVP + ES + usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study: 36034207

Group type: EXPERIMENTAL
Intervention: Entresto 50 mg + basic treatment
Number of subjects: 78

Group type: COMPARATOR
Intervention: Basic treatment
Number of subjects: 78
Study: 34164855

Group type: EXPERIMENTAL
Intervention: 30 mg/day of crocin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 33267734

Group type: EXPERIMENTAL
Intervention: Barbed suture
Number of subjects: 184

Group type: COMPARATOR
Intervention: Conventional interrupted sutures
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 184
Study: 34706980

Group type: EXPERIMENTAL
Intervention: High-frequency airway oscillation (HFAO) device (Aerosure)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 104
Study: 33920012

Group type: EXPERIMENTAL
Intervention: Suicide prevention public service announcements (PSAs) - 'Talk to someone', 'Find what works for you', 'Life can get better'
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Suicide prevention public service announcements (PSAs)
Number of subjects: 15
Study: 35329218

Group type: EXPERIMENTAL
Intervention: Interactive-video games, 60 min group-based training program once per week for 12 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 16
Study: 33620272

Group type: EXPERIMENTAL
Intervention: <4 years
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 5-7 years
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 8-18 years
Number of subjects: 78
Study: 32508221

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR; 6 mmol nitrate)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA; 0.0034 mmol nitrate)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR; 11.8 ± 2.5 mM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA; 12.2 ± 2.3 mM)
Number of subjects: 16
Study: 36228807

Group type: EXPERIMENTAL
Intervention: Group 1 (AL = 0‰)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Group 2 (AL = 0-0.5‰)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Group 3 (AL ≥ 0.5‰)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control (AL = 0‰)
Number of subjects: 352
Study: 32925494

Group type: EXPERIMENTAL
Intervention: Sitting interrupted by 3-min bouts of simple resistance activities (SRA) every 30 min
Number of subjects: 13

Group type: COMPARATOR
Intervention: Uninterrupted sitting (SIT)
Number of subjects: 13
Study: 35534868

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) environment for relaxation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Active control group applying a freely chosen relaxation method
Number of subjects: 100
Study: 32820431

Group type: EXPERIMENTAL
Intervention: Probiotic lozenges administered twice daily for 5 days (subgroup AI)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Probiotic lozenges administered twice daily for 5 days (subgroup BI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control subgroup AII
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control subgroup BII
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Subgroup BI
Number of subjects: 120
Study: 33501741

Group type: EXPERIMENTAL
Intervention: Doxycycline treatment (antibiotic group)
Number of subjects: 222

Group type: COMPARATOR
Intervention: No antibiotics (non-antibiotic group)
Number of subjects: 222
Study: 32982191

Group type: EXPERIMENTAL
Intervention: Monthly professional cleaning and individual oral hygiene instructions by registered dental hygienists (RDHs)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Daily oral care as usual (self‐performed or nursing staff‐assisted)
Number of subjects: 146
Study: 35948377

Group type: EXPERIMENTAL
Intervention: rTMS for 3 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham rTMS for 3 weeks
Number of subjects: 34
Study: 33486762

Group type: EXPERIMENTAL
Intervention: Classical Hodgkin lymphoma (cHL) treatment
Number of subjects: 11841

Group type: EXPERIMENTAL
Intervention: NHL diagnosis
Number of subjects: 11841

Group type: EXPERIMENTAL
Intervention: Event-free survival after NHL diagnosis
Number of subjects: 11841

Group type: EXPERIMENTAL
Intervention: Overall survival after NHL diagnosis
Number of subjects: 11841
Study: 35436970

Group type: EXPERIMENTAL
Intervention: Direct adjustment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inverse-probability-of-treatment weighting (IPTW)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardisation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Missing outcome data handling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GetTested trial
Number of subjects: 0
Study: 35101325

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33909857

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise training over 16 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (CG) following their own daily activities
Number of subjects: 21
Study: 36260627

Group type: EXPERIMENTAL
Intervention: favipiravir+placebo
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir+placebo
Number of subjects: 240

Group type: COMPARATOR
Intervention: placebo only
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: favipiravir+lopinavir-ritonavir
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir
Number of subjects: 240
Study: 33280968

Group type: EXPERIMENTAL
Intervention: Patient education and decision aid tool about prescription pain relievers (N = 65)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Time-matched control (N = 59)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Patient education and decision aid tool
Number of subjects: 124
Study: 33620550

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (200 mg/day)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (rice flour)
Number of subjects: 88
Study: 32701931

Group type: EXPERIMENTAL
Intervention: Chronic TMD group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Asymptomatic group
Number of subjects: 30
Study: 36085061

Group type: EXPERIMENTAL
Intervention: OAD with antihypertensive drugs (test group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: OAD without hypertension (control group)
Number of subjects: 180
Study: 34606574

Group type: EXPERIMENTAL
Intervention: Topical racemic epinephrine pellets
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline pellets
Number of subjects: 13
Study: 32807173

Group type: EXPERIMENTAL
Intervention: Concentrated growth factors (CGF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-concentrated growth factors (Control)
Number of subjects: 70
Study: 34352600

Group type: EXPERIMENTAL
Intervention: Moderate aquatic aerobic exercise with usual antenatal care
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual prenatal care alone
Number of subjects: 320
Study: 32022954

Group type: EXPERIMENTAL
Intervention: Synthetic midurethral sling procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical investigations and surgical treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized-controlled trials
Number of subjects: 0
Study: 34115959

Group type: EXPERIMENTAL
Intervention: Closed-Loop Control (CLC)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Sensor-Augmented Pump (SAP)
Number of subjects: 168
Study: 34896609

Group type: EXPERIMENTAL
Intervention: Intradiscal oxygen-ozone
Number of subjects: 49

Group type: COMPARATOR
Intervention: Microdiscectomy
Number of subjects: 49
Study: 34547486

Group type: EXPERIMENTAL
Intervention: Group A (0.25 mL rabies vaccine at day 0, 7 with IIV4)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Group B (0.25 mL rabies vaccine at day 0, 28 with IIV4)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Group C (0.25 mL rabies vaccine at day 0, 7)
Number of subjects: 100
Study: 35655733

Group type: EXPERIMENTAL
Intervention: Self-designed comprehensive pelvic floor training
Number of subjects: 88

Group type: COMPARATOR
Intervention: Kegel motion (control group)
Number of subjects: 88
Study: 32648175

Group type: EXPERIMENTAL
Intervention: Completely Minimally Invasive Esophagectomy (CMIE)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Hybrid Esophagectomy (HE)
Number of subjects: 147
Study: 33067294

Group type: EXPERIMENTAL
Intervention: Active recruitment strategy (personal invitation by memory clinic team)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Passive recruitment strategy (poster and flyer in waiting room)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Online tailor-made lifestyle advice regarding protective and risk factors for dementia
Number of subjects: 378
Study: 35984998

Group type: EXPERIMENTAL
Intervention: Geriatric assessment (GA) intervention with summary and management recommendations provided to oncologists.
Number of subjects: 541

Group type: COMPARATOR
Intervention: Usual care without GA summary provided to oncologists.
Number of subjects: 541
Study: 32858111

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Insulin Use
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Nonwhite Race
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Nodal Involvement
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: CA19-9 ≥90 U/mL
Number of subjects: 238